Developmental MC + neuropsych — developmental-window framework for adult FM precursor

One-paragraph summary

Review of mast cell biology + neuroinflammation in childhood/adolescent neuropsychiatric disorders (ADHD, autism spectrum disorder, epilepsy, anxiety, depression). Key mechanism elements: MC enrichment in specific nervous-system regions and the GI tract, MC-microglia interactions, MC release of histamine and neuropeptides (substance P) driving developmental neuroinflammation. This is a developmental-window mechanism candidate for adult FM precursor framing — childhood MC programming and developmental MC-microglia interactions could be the upstream event that establishes the H2 (mast cell) chain phenotype in adult FM. Specifically: a child with adverse early-life experience or post-viral MC priming could enter adulthood with a primed H2 mast-cell-substance-P-microglia axis that subsequently amplifies into adult FM under a triggering event (viral infection, physical trauma, sustained stress — already in the project's trigger ontology).

Claims as triples

• mast_cell — enriched_in → specific_nervous_system_regions [evidence: review consolidation of anatomical studies; confidence: established]
• mast_cell — enriched_in → gastrointestinal_tract [evidence: review; confidence: established]
• mast_cell_substance_P_release — drives → developmental_neuroinflammation [evidence: review consolidation; confidence: emerging]
• mast_cell_microglia_interaction — operates_in → developmental_neuropsychiatric_disorders [evidence: review; confidence: emerging]
• mast_cell_histamine_release — promotes → developmental_neuroinflammation [evidence: review; confidence: emerging]
• mast_cell_activation — implicated_in → autism_spectrum_disorder [evidence: review; confidence: emerging]
• mast_cell_activation — implicated_in → ADHD [evidence: review; confidence: emerging]
• mast_cell_activation — implicated_in → developmental_epilepsy [evidence: review; confidence: emerging]
• mast_cell_activation — implicated_in → developmental_anxiety_disorders [evidence: review; confidence: emerging]
• mast_cell_activation — implicated_in → developmental_depression [evidence: review; confidence: emerging]

Methods note

Narrative review consolidating MC + neuroinflammation findings across developmental neuropsychiatric conditions. The MC-substance-P-microglia axis described mirrors the adult FM mechanism (Aitella 2026 — MC-SP bidirectional loop via MRGPRX2/NK1R, already in project). The cross-condition consolidation is the contribution; primary FM-direct work is absent (the disorders covered are developmental-age, not FM).

Limitations

• Narrative not systematic
• Adult-FM extrapolation is project-driven, not paper-driven (paper doesn't discuss adult FM)
• Heterogeneous evidence across developmental conditions; not all claims are equally well-supported
• No FM-precursor framing within paper itself
• Developmental MC literature is rapidly evolving; specific findings may need replication

Open questions raised

• Q-Dev-MC-1 (new): Do FM patients with childhood-onset symptoms (allergic conditions, atopic dermatitis, recurrent abdominal pain, ADHD/anxiety diagnoses) have a higher H2-chain phenotype severity in adulthood than FM patients without childhood markers? Adult-FM cohort study with retrospective childhood-symptom screening would test this.
• Q-Dev-MC-2 (new): Is childhood MC priming protective or hazardous for adult FM? Both directions are plausible: persistent MC activation could exhaust mediator stores, or could prime the H2 axis for chronic dysregulation.
• Q-Dev-MC-3 (new): Do early-life H1 receptor antagonists (loratadine, cetirizine), MC stabilizers (cromolyn, ketotifen), or substance-P pathway interventions reduce adult-FM incidence in genetically-predisposed children? Prospective birth-cohort design needed.
• Q-Dev-MC-4 (new): Is hereditary alpha-tryptasemia (HαT; TPSAB1 duplication — already in project via Lyons 2019 + Simeone 2026) a developmental-vulnerability marker for adult FM? HαT is genetic and present from birth; its developmental-period expression as MC primer for adult FM is a testable hypothesis.

Triangulation notes

• Provides developmental layer for H2 chain: H2 mast-cell chain in adult FM (Sanchez 2025, Aitella 2026, Amato 2026, Simeone 2026 — all already in project) operates at the adult cell-and-receptor level. This paper supplies the candidate developmental setup: childhood MC priming → adolescent MC dysregulation → adult FM under triggering event. The chain gains a developmental-time-axis dimension.
• Compatible with TPSAB1/HαT framing (Lyons 2019 + Simeone 2026 already in project): HαT operates from birth as a hereditary MC amplifier; this review's developmental-MC framework provides the time-axis context for HαT's role across the lifespan.
• Connects to the project's existing trigger ontology: viral_infection, physical_trauma, sustained_stress are already FM trigger entities. This paper supplies the missing developmental-window dimension — these triggers may have a more severe effect when applied during MC-developmental-priming windows.
• Compatible with Wirth-Scheibenbogen ME/CFS framework: ME/CFS often has post-viral childhood/adolescent onset; the developmental-MC framing extends to post-viral developmental MC priming.

Bridges

• B-DevMC (NEW candidate): Developmental MC programming ↔ adult FM via H2 chain. Bridging tier — predicted developmental upstream of an established adult mechanism. Closing would require birth-cohort or retrospective developmental-history studies in FM patients.

Ontology additions needed

• Consider adding developmental_mast_cell_programming as new entity (process)
• Consider adding autism_spectrum_disorder, ADHD, developmental_epilepsy as candidate childhood-precursor entities at bridging confidence
• Consider adding childhood_allergic_phenotype as developmental marker

Chain-map update

• H2 chain time-axis extension: H2 chain (MC) should be reframed as having a developmental-window precursor phase (childhood MC priming) and an adult-trigger phase (FM onset). The reframing is bridging-tier; closing requires developmental-history studies in adult FM cohorts.

Confidence-tier framing

• Developmental MC roles in childhood neuropsychiatric conditions: emerging (review consolidation of primary work)
• Adult FM precursor framing: bridging (project-internal extrapolation, paper does not discuss adult FM)
• Childhood symptom markers as FM-vulnerability predictors: inferred (predicted by framework; no FM-direct evidence yet)